合計: 38 |
|
PMID (PMCID) | ||
---|---|---|
29866231 |
MALE | Middle Aged |
Lenalidomide Induced Toxic Epidermal Necrolysis and Del (5q): Co-occurrence of Rarities. | ||
Chaudhry QUN, Iftikhar R, Satti TM, Mahmood SK, Khan MA, Shahbaz N. J Coll Physicians Surg Pak. 2018;28(6):S89-S90. |
||
Primary myelofibrosis (PMF) is a clonal, BCR-ABL1 negative myeloproliferative neoplasm characterised by splenomegaly, leukoerythroblastic peripheral blood picture and bone marrow fibrosis. | ||
29350220 (5715205) |
OTHER | |
Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era. | ||
Del Sordo R, Brugnano R, Covarelli C, Fiorucci G, Falzetti F, Barbatelli G, Nunzi E, Sidoni A. Clin Nephrol Case Stud. 2017;5:70-77. |
||
Primary myelofibrosis (PMF) is an uncommon form of myeloproliferative neoplasm (MPN) characterized by a proliferation of predominantly megakaryocytes and granulocytes in the bone marrow that, in fully-developed disease, is associated with reactive deposition of fibrous connective tissue, extramedullary hematopoiesis (EMH), and splenomegaly. | ||
28775247 (5551928) |
MALE | Middle Aged |
Spinal Abscess Caused by Salmonella Bacteremia in a Patient with Primary Myelofibrosis. | ||
Fareed S, Nashwan AJ, Abu Jarir S, Husain A, Suliman DS, Ibrahim F, Moustafa A, Akhter MS, Yassin MA. Am J Case Rep. 2017;18:859-864. |
||
CASE REPORT We are reporting the case of a 50-year-old male with primary myelofibrosis and long-standing splenomegaly with back pain as a presenting symptom who was found to have spinal cord compression. | ||
27734802 |
MALE | Middle Aged |
An usual cause of elliptocytosis. | ||
Broseus J, Roth-Guepin G, D'Aveni-Piney M, Perrot A, Lesesve JF, Perrin J. Ann Biol Clin (Paris). 2016;74(6):704-707. |
||
The objectification of elliptocytosis accompanied by splenomegaly, a collagen myelofibrosis and the presence of the mutation JAK2V617F allowed the diagnosis of primary myelofibrosis with atypical initial presentation. | ||
25034748 |
MALE | |
Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation. | ||
Beauverd Y, Samii K. Int J Hematol. 2014;100(5):498-501. |
||
We present a case of a 76-year-old man diagnosed with primary myelofibrosis who presented with constitutional symptoms and symptomatic splenomegaly. | ||
25741217 (4347479) |
OTHER | |
Translocation t(3;12)(q26;q21) in JAK2(V617F) Point Mutation Negative Chronic Idiopathic Myelofibrosis: A Case Report. | ||
Meanovic S, ahovic H, Peric M. Balkan J Med Genet. 2014;17(1):63-8. |
||
Chronic idiopathic myelofibrosis (CIMF) is a stem cell defect characterized by splenomegaly with multiorgan extramedullary hematopoiesis, immature peripheral blood granulocytes and erythrocytes and progressive bone marrow fibrosis. | ||
23039051 (3515333) |
MALE | |
Disseminated tuberculosis in a patient treated with a JAK2 selective inhibitor: a case report. | ||
Colomba C, Rubino R, Siracusa L, Lalicata F, Trizzino M, Titone L, Tolomeo M. BMC Res Notes. 2012;5:552. |
||
Primary myelofibrosis is a myeloproliferative disorder characterized by bone marrow fibrosis, abnormal cytokine expression, splenomegaly and anemia. | ||
21393891 |
MIXED_SAMPLE | Middle Aged |
JAK2-positive Philadelphia-negative myeloproliferative neoplasms. | ||
Sharma A, Buxi G, Marwah S, Yadav R. Indian J Pathol Microbiol. 2011;54(1):117-20. |
||
Here are two cases which incidentally presented with splenomegaly and moderate leukocytosis, and were diagnosed as MPN-primary myelofibrosis (PMF) in prefibrotic phase and polycythemia vera (PV), respectively, using revised World Health Organization (WHO) 2008 criteria. | ||
20181038 (2830976) |
OTHER | |
Acute variceal bleeding in a patient with idiopathic myelofibrosis successfully treated with endoscopic variceal band ligation and chemotherapy: a case report. | ||
Tamaki K, Otaka M, Sakamoto N, Matsumoto K, Yamashina S, Watanabe S. J Med Case Rep. 2010;4:25. |
||
Idiopathic myelofibrosis is a chronic myeloproliferative disorder characterized by leukoerythroblastosis, massive splenomegaly, and increases in the reticular and collagen fibers in the bone marrow. | ||
20949707 |
MALE | Middle Aged |
Bilateral ureteral obstruction due to primary myelofibrosis caused hyperuricaemia. | ||
Cvetkovic ZP, Cvetkovic BR, Celeketic D, Milenkovic D, Perunicic-Pekovic G. Acta Chir Iugosl. 2010;57(2):79-83. |
||
Primary melofibrosis (Agnogenic myeloid metaplasia-AMM) is a chronic myeloproliferative disease characterized by splenomegaly, a leukoerythroblastic blood picture, teardrop poikilocytosis and varying degrees of marrow fibrosis. | ||
22958626 (3436631) |
OTHER | |
Pulmonary hypertension diagnosed by echocardiography during idiopathic myelofibrosis. A case report and a brief review of the literature. | ||
Perrone C, Cartolari R, Lupi B, Morelli S. Multidiscip Respir Med. 2010;5(4):267-70. |
||
Idiopathic myelofibrosis is a rare chronic myeloproliferative disease leading to extramedullary hematopoiesis (myeloid metaplasia) with splenomegaly. | ||
20700988 |
FEMALE | Adult |
[Agnogenic myeloid metaplasia in pregnancy. Case report]. | ||
Manole I, Costachescu G, Aldea MJ, Gavrilut M, Dumitrascu I. Rev Med Chir Soc Med Nat Iasi. 2010;114(2):465-9. |
||
Idiopathic myelofibrosis is a rare myeloproliferative disorder characterized by excessive accumulation of connective tissue in the bone marrow in association with anemia, splenomegaly and extramedullary hematopoiesis. | ||
16321815 |
MALE | |
Agnogenic myeloid metaplasia with pulmonary hematopoiesis. | ||
Boula A, Mantadakis E, Xilouri I, Foudoulakis A, Samonis G. Hematology. 2005;10(6):501-3. |
||
Agnogenic myeloid metaplasia (AMM) is characterized by bone marrow fibrosis, splenomegaly and leukoerythroblastic anemia and is frequently accompanied by extramedullary hematopoiesis (EMH). | ||
14629130 |
FEMALE | Middle Aged |
Reversal of marrow fibrosis in agnogenic myeloid metaplasia by allogeneic peripheral blood stem cell transplantation. | ||
Udomsakdi-Auewarakul C, Visuthisakchai S, Sangruchi T, Issaragrisil S. Asian Pac J Allergy Immunol. 2003;21(2):121-6. |
||
Agnogenic myeloid metaplasia (AMM) is a clonal hematopoietic stem cell disorder characterized by bone marrow fibrosis, extramedullary hemopoiesis, splenomegaly and a leukoerythroblastic blood picture. | ||
12884816 |
MALE | Middle Aged |
[Fatal septic shock and rhabdomyolysis following transfusion of platelet concentrates contaminated with Streptococcus pneumoniae]. | ||
Katayama T, Kamiya M, Hoshina S, Masuoka H, Nishiwaki K, Sano K, Hagino T, Kobayashi M. Rinsho Ketsueki. 2003;44(6):381-5. |
||
The initial diagnosis of primary myelofibrosis was established by splenomegaly, leukoerythroblastosis and bone marrow fibrosis. | ||
11167703 |
FEMALE | Middle Aged |
A case of porphyria cutanea tarda in association with idiopathic myelofibrosis and CREST syndrome. | ||
Lee SC, Yun SJ, Lee JB, Lee SS, Won YH. Br J Dermatol. 2001;144(1):182-5. |
||
She had presented with splenomegaly 3 years before the development of PCT, and was diagnosed as having idiopathic myelofibrosis, based on bone marrow biopsy. | ||
11293952 |
MALE | Middle Aged |
Idiopathic myelofibrosis complicated by portal hypertension treated with a transjugular intrahepatic portosystemic shunt (TIPS). | ||
Belohlavek J, Schwarz J, Jirasek A, Krajina A, Polak F, Hruby M. Wien Klin Wochenschr. 2001;113(5-6):208-11. |
||
The authors report a 56-year-old man with idiopathic myelofibrosis and splenomegaly complicated by hepatopathy, severe portal hypertension and recurrent variceal bleeding. | ||
8846142 |
MALE | Child |
Successful allogeneic bone marrow transplantation for agnogenic myeloid metaplasia in a 3-year-old boy. | ||
Rossbach HC, Grana NH, Chamizo W, Barrios NJ, Barbosa JL. J Pediatr Hematol Oncol. 1996;18(2):213-5. |
||
Agnogenic myeloid metaplasia (AMM) is a myeloproliferative disorder characterized by marrow fibrosis, extramedullary hematopoiesis, splenomegaly, and leukoerythroblastosis with abnormalities of red blood cell morphology. | ||
8667677 |
FEMALE | Middle Aged |
[Splenomegalic pancytopenia of probable immune origin: cure after treatment with glucocorticoids]. | ||
Fuentes A, Feliu E, Blade J, Campo E, Ribera JM, Cervantes F, Rozman C. Med Clin (Barc). 1996;106(7):263-6. |
||
The origin of the process was attributed probably to an immune etiology and differential diagnosis with idiopathic myelofibrosis and non tropical idiopathic splenomegaly must be considered. | ||
7563614 |
FEMALE | Middle Aged |
[Aplastic anemia with giant splenomegaly and myelofibrosis successfully treated with antilymphocyte globulin]. | ||
Kaito K, Otsubo H, Ogasawara Y, Sekita T, Saeki A, Nishiwaki K, Masuoka H, Shimada T, Yoshida M, Kobayashi M, et al.. Rinsho Ketsueki. 1995;36(8):786-91. |
||
Splenomegaly and myelofibrosis are characteristic of primary myelofibrosis and although the relationship is uncertain, there is no previous report on aplastic anemia with splenomegaly and myelofibrosis. |